Some 77 countries experienced their highest average annual...
Category:
Disaster & Management
Latest
Climate change makes forecasting harder, says Australia’s agriculture minister
“Climate change is having an impact. The models that we’ve...
ECB cyber stress test not to affect capital requirements
The exercise will assess how banks respond to and recover from a...
It’s not for me:speed of COVID-19 vaccine race raises safety concerns
Regulators around the world have repeatedly said speed will not compromise safety, as quicker results would stem from conducting in parallel trials that are usually done in sequence.
However, these reassurances have failed to convince many, including in Western countries where scepticism about vaccinations was already growing before the pandemic.
Preliminary results of a survey conducted over the last three months in 19 countries showed that only about 70% of British and U.S. respondents would take a COVID-19 vaccine if available, Scott Ratzan, co-leader of ‘Business Partners to CONVINCE’, told Reuters.
10 countries account for 80% of Africa COVID-19 testing:Africa CDC
COVID-19 confirmed cases across Africa have accelerated and are close to hitting a million this week, and experts say low levels of testing in many countries means infection rates are likely to be higher than reported.
Container ships sent to Tripoli to keep Lebanon supply lines running
Ship insurer Gard said: “According to our correspondents, the port of Beirut is closed for a minimum period of 14 days which could be extended until port facilities have been restored.”
The International Transport Workers’ Federation, which represents seafarers, quoted its representatives in Lebanon as saying at least 12 dockers and seven separate seafarers had been killed in the port. The figure could not be independently confirmed.
Lebanon, which imports almost all it uses, relies on container ships to bring in everything from refrigerated food cargoes to clothing and other consumer goods.
There is no firm date for Beirut port to re-open, and this is a strain on supply chains.
Zydus Cadila’s COVID-19 vaccine candidate found safe in early-stage human trial
Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially, the company’s chairman told Reuters last month.
India reported a daily jump of more than 50,000 coronavirus infections for the seventh straight day on Wednesday.Total cases now stand at 1.91 million, the third biggest, after the United States and Brazil
90% of recovered COVID-19 patients in Wuhan suffering from lung damage:report
According to the first phase results, 90 per cent of the patients” lungs are still in a damaged state, which means their lungs ventilation and gas exchange functions have not recovered to the level of healthy people, state-run Global Times reported.
Some recovered patients have to rely on oxygen machines even three months after being discharged from the hospital, Liang Tengxiao, a doctor from the Dongzhimen Hospital, Beijing University of Chinese Medicine, was quoted as saying by the report.
Indian pharma majors race ahead to launch affordable drugs for Covid-19 treatment
Drug major Cipla is working with government agencies to develop a treatment for COVID-19 while ramping up the production of various life saving essential drugs, according to company’s chairman YK Hamied.
Drug firm BDR Pharmaceuticals on Wednesday said it has launched its antiviral drug Favipiravir for the treatment of COVID-19 patients in India at a price of Rs 63 per tablet.
Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name ‘Covihalt’ for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.
Global coronavirus deaths exceed 700,000, one person dies every 15 seconds on average
Even in parts of the world that had appeared to have curbed the spread of the virus, countries have recently seen single-day records in new cases, signaling the battle is far from over. Australia, Japan, Hong Kong, Bolivia, Sudan, Ethiopia, Bulgaria, Belgium, Uzbekistan and Israel all recently had record increases in cases.
Proportion of youth with COVID-19 triples in five months: WHO
An analysis by the WHO of 6 million infections between Feb. 24 and July 12 found that the share of people aged 15-24 years rose to 15% from 4.5%.
Apart from the United States which leads a global tally with 4.8 million total cases, European countries including Spain, Germany and France, and Asian countries such as Japan, have said that many of the newly infected are young people.
“Younger people tend to be less vigilant about masking and social distancing,” Neysa Ernst, nurse manager at Johns Hopkins Hospital’s biocontainment unit in Baltimore, Maryland told Reuters in an email.
How the pandemic may change ‘work-life balance’ forever
Some of the best companies for work-life balance] have really great paid-time off policies, flexible working schedules, good parental leave, sabbaticals and gym credits,” said Amanda Stansell, senior research analyst at workplace website Glassdoor. But as workers shifted to remote work, the spirit of in-person events and company culture needed to be recreated at home
Are pharma companies are trying to profiteer from Covid-19 vaccines
If a vaccine proves too expensive or difficult to obtain, those who seek exorbitant profits off of it will be scrutinized far more closely than bankers were after the 2008 crash. Actions like those that have already allowed insiders to pocket $80 million will provoke public revulsion, even if those trades were pre-scheduled. Calls to regulate sectors that take for granted intellectual property protections will grow exponentially. Those demands won’t be fanatical or radical, but mainstream.